Pharmacologic profiling of corifollitropin alfa, the first developed sustained follicle stimulant

European Journal of Pharmacology

Volumn 651, Issue 1-3, 2011, Pages 227-233

  Verbost, Pieter ^a   Sloot, Willem N ^b   Rose, Ursula M ^a   De Leeuw, Renato ^b   Hanssen, Rob G J M ^b   Verheijden, Gijs F M ^b  

^a NV ORGANON   (Netherlands)

^b MSD   (Netherlands)

Author keywords

Controlled ovarian stimulation; Corifollitropin alfa; CTP (carboxy terminal peptide); Elonva ; FSH (follicle stimulating hormone); IVF (in vitro fertilization)

Indexed keywords

CORIFOLLITROPIN ALFA; ESTRADIOL; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; PROGESTERONE; RECOMBINANT FOLLITROPIN; THYROTROPIN RECEPTOR;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHO CELL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE RECEPTOR INTERACTION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; ORGAN WEIGHT; OVARY; OVULATION INDUCTION; PHARMACODYNAMICS; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RAT; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SINGLE DRUG DOSE; SUPEROVULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSACTIVATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DOGS; DRUG DISCOVERY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; ORGAN SIZE; OVARY; PROGESTERONE; RATS; RECEPTORS, FSH; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 78650677079     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.078     Document Type: Article

References (27)

1. S. Creus, Z. Chaia, E.H. Pellizzari, S.B. Cigorraga, A. Ulloa-Aguirre, and S. Campo Human FSH isoforms: carbohydrate complexity as determinant of in-vitro bioactivity Mol. Cell. Endocrinol. 174 2001 41 49
2. M. D'Antonio, F. Borrelli, A. Datola, R. Bucci, M. Mascia, P. Polletta, D. Piscitelli, and R. Papoian Biological characterization of recombinant human follicle stimulating hormone isoforms Hum. Reprod. 14 1999 1160 1167
3. R. De Leeuw, J. Mulders, G. Voortman, F. Rombout, J. Damm, and L. Kloosterboer Structure-function relationship of recombinant follicle stimulating hormone (Puregon) Mol. Hum. Reprod. 2 1996 361 369 (Pubitemid 126717451)
4. P. Devroey, R. Boostanfar, N.P. Koper, B.M. Mannaerts, P.C. Ijzerman-Boon, and B.C. Fauser A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum. Reprod. 24 2009 3063 3072
5. I.J. Duijkers, C. Klipping, P.J. Boerrigter, C.S. Machielsen, J.J. De Bie, and G. Voortman Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Hum. Reprod. 17 2002 1987 1993
6. F.A. Fares, N. Suganuma, K. Nishimori, P.S. LaPolt, A.J. Hsueh, and I. Boime Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit Proc. Natl Acad. Sci. USA 89 1992 4304 4308
7. H.M. Fatemi, J. Oberye, B. Popovic-Todorovic, H. Witjes, B. Mannaerts, and P. Devroey Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial Fertil. Steril. 94 2010 1922 1924 (Epub ahead of print February)
8. B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baired Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum. Reprod. Update 15 2009 309 321
9. C.M. Howles Genetic engineering of human FSH (Gonal-F) Hum. Reprod. Update 2 1996 172 191
10. J. Klein, L. Lobel, S. Pollak, M. Ferin, E. Xiao, M. Sauer, and J.W. Lustbader Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey Fertil. Steril. 77 2002 1248 1255
11. P.S. LaPolt, K. Nishimori, F.A. Fares, E. Perlas, I. Boime, and A.J. Hsueh Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides Endocrinology 131 1992 2514 2520
12. Leader A., Witjes H., Mannaerts B., and Gordon K. Ongoing pregnancy rates with corifollitropin alfa/gonadotrophin-releasing hormone (GnRH) antagonist regimen are not impacted by endogenous luteinizing hormone (LH) levels Presented at: 65th Annual Meeting of the American Society for Reproductive Medicine; October 17-21, 2009. Atlanta, GA 2009
13. B. Lunenfeld Historical perspectives in gonadotrophin therapy Hum. Reprod. Update 10 2004 453 467
14. N.S. Macklon, R.L. Stouffer, L.C. Giudice, and B.C. Fauser The science behind 25 years of ovarian stimulation for in vitro fertilization Endocr. Rev. 27 2006 170 207
15. H.D. Mason, D.S. Willis, R.W. Beard, R.M. Winston, R. Margara, and S. Franks Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid J. Clin. Endocrinol. Metab. 79 1994 1355 1360
16. M.M. Matzuk, A.J. Hsueh, P. Lapolt, A. Tsafriri, J.L. Keene, and I. Boime The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit Endocrinology 126 1990 376 383
17. W. Olijve, W. de Boer, J.W. Mulders, and P.M. van Wezenbeek Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon) Mol. Hum. Reprod. 2 1996 371 382
18. Pang S.C. Use of follicle-stimulating hormone for the treatment of female infertility - current concepts Womens Health (Lond. Engl.) 1 2005 87 95
19. E.G. Papanikolaou, E. Kolibianakis, and P. Devroey Emerging drugs in assisted reproduction Expert Opin. Emerg. Drugs 10 2005 425 440
20. Perlman S., H.B. van den, Christiansen J., Gram-Nielsen S., Jeppesen C.B., Andersen K.V., Halkier T., Okkels S., and Schambye H.T. Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone J. Clin. Endocrinol. Metab. 88 2003 3227 3235
21. J.G. Pierce, and T.F. Parsons Glycoprotein hormones: structure and function Annu. Rev. Biochem. 50 1981 465 495
22. J.I. Ruman, S. Pollak, R.K. Trousdale, J. Klein, and J.W. Lustbader Effects of long-acting recombinant human follicle-stimulating hormone analogs containing N-linked glycosylation on murine folliculogenesis Fertil. Steril. 83 Suppl 1 2005 1303 1309
23. Ryan R.J., Charlesworth M.C., McCormick D.J., Milius R.P., and Keutmann H.T. The glycoprotein hormones: recent studies of structure-function relationships FASEB J. 2 1988 2661 2669
24. S.L. Steelman, and F.M. Pohley Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin Endocrinology 53 1953 604 616
25. H.A. Stockell, and A.G. Renwick Molecular structures of glycoprotein hormones and functions of their carbohydrate components Biochem. J. 287 Pt 3 1992 665 679
26. A. van Schanke, S.F. van de Wetering-Krebbers, E. Bos, and W.N. Sloot Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity Pharmacology 85 2010 77 87
27. C. Weenen, J.E. Pena, S.V. Pollak, J. Klein, L. Lobel, R.K. Trousdale, S. Palmer, E.G. Lustbader, R.T. Ogden, and J.W. Lustbader Long-acting follicle-stimulating hormone analogs containing N-linked glycosylation exhibited increased bioactivity compared with O-linked analogs in female rats J. Clin. Endocrinol. Metab. 89 2004 5204 5212